Indoco Remedies

38
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
251.80
-0.1 (-0.04%)
BSENSE

Dec 05

BSE+NSE Vol: 7.33 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Indoco Remedies Cash flow Statement
Figures in Cr
Consolidated Cash Flow Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-75.00
124.00
192.00
236.00
132.00
28.00
Adjustment
183.00
137.00
120.00
87.00
109.00
99.00
Changes In working Capital
2.00
-88.00
-73.00
-108.00
-139.00
-1.00
Cash Flow after changes in Working Capital
111.00
173.00
240.00
214.00
101.00
126.00
Cash Flow from Operating Activities
94.00
155.00
178.00
173.00
82.00
122.00
Cash Flow from Investing Activities
-339.00
-431.00
-208.00
-121.00
-66.00
-55.00
Cash Flow from Financing Activities
241.00
280.00
22.00
-44.00
-29.00
-63.00
Net Cash Inflow / Outflow
-2.00
3.00
-6.00
8.00
-14.00
2.00
Opening Cash & Cash Equivalents
14.00
10.00
17.00
9.00
23.00
20.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
12.00
14.00
10.00
17.00
9.00
23.00
Figures in INR Cr
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Indoco Remedies
Markets Mojo
Figures in Cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
-75.36
137.96
-212.00
-154.62%
Adjustment
183.64
79.85
104.00
129.98%
Changes In working Capital
2.78
-20.87
22.00
113.32%
Cash Flow after changes in Working Capital
111.06
196.94
-85.00
-43.61%
Cash Flow from Operating Activities
94.93
178.62
-84.00
-46.85%
Cash Flow from Investing Activities
-339.11
-154.18
-185.00
-119.94%
Cash Flow from Financing Activities
241.42
46.04
195.00
424.37%
Net Cash Inflow / Outflow
-2.76
70.48
-72.00
-103.92%
Opening Cash & Cash Equivalents
14.86
7.69
7.00
93.24%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
12.1
78.17
-66.00
-84.52%
Cash Flow - Snapshot (Consolidated) - Mar'25
stock-summary

YoY Growth in year ended Mar 2025 is -38.91% vs -13.11% in Mar 2024

Mar'25
Mar'24
Change(%)
Cash Flow from Operating Activities
94.93
155.39
-38.91%